Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Board Member, CEO at Applied Proteomics


Applied Proteomics announced this week that it has appointed Peter Klemm as CEO and James Blair to its board of directors.

Klemm is currently chairman of Pathwork Diagnostics and was previously the CEO and president of Predictive Biosciences. He was also CEO of GeneOhm Sciences, which was acquired by Becton Dickinson.

Blair is a founding partner at Domain Associates, which recently participated in API's $22.5 million Series B funding round (See story, this issue).